Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain

ClinicalTrials.gov ID: NCT02793817

Public ClinicalTrials.gov record NCT02793817. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Efficacy of KPI-121 1.0% Ophthalmic Suspension in Subjects With Postsurgical Inflammation and Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to investigate the efficacy and safety of KPI-121 1.0% ophthalmic suspension compared to placebo in subjects who have undergone cataract surgery.

Study identification

NCT ID
NCT02793817
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kala Pharmaceuticals, Inc.
Industry
Enrollment
520 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2016
Primary completion
Feb 28, 2017
Completion
Feb 28, 2017
Last update posted
Dec 15, 2020

2016 – 2017

United States locations

U.S. sites
35
U.S. states
16
U.S. cities
35
Facility City State ZIP Site status
Arizona Eye Center Chandler Arizona 85225
Cornea and Cataract Consultants of CA Phoenix Arizona 85032
Sall Research Medical Center Artesia California 90701
Orange County Ophthalmology Garden Grove California 92843
Lugene Eye Institute Glendale California 91204
Inland Eye Specialists Hemet California 92545
United Medical Research Institute Inglewood California 90301
LoBue Laser and Eye Medical Center Murrieta California 92562
Pendleton Eye Center Oceanside California 92056
North Bay Eye Associates, Inc. Petaluma California 94954
Arch Health Partners Poway California 92064
Martel Eye Medical Group Rancho Cordova California 95670
Shasta Eye Medical Group, Inc Redding California 96002
Eye Center of Northern Colorado, PC Fort Collins Colorado 80525
Eye Associates of Fort Myers Fort Myers Florida 33901
Levenson Eye Associates Jacksonville Florida 32204
Shettle Eye Research, Inc Largo Florida 33773
International Research Center Tampa Florida 33603
Chicago Cornea Consultants, Ltd. Hoffman Estates Illinois 60169
Jacksoneye, S. C. Lake Villa Illinois 60046
The Eye Care Institute Louisville Kentucky 40206
Great Lakes Eye Care Saint Joseph Michigan 49085
Minnesota Eye Consultants, PA Bloomington Minnesota 55431
Comprehensive Eye Care, Ltd. / Vision Research Institute, LLC Washington Missouri 63090
Abrams Eye Institute Las Vegas Nevada 89148
Duke University Eye Center Durham North Carolina 27703
Apex Eye Cincinnati Ohio 45247
Roseburg Research Associates, LLC Roseburg Oregon 97471
Eye Care Specialists Kingston Pennsylvania 18704
Carolina Cataract & Laser Center Ladson South Carolina 29456
Carolina Eyecare Physicians, LLC Mt. Pleasant South Carolina 29464
Texan Eye, PA / Keystone Research, Ltd Austin Texas 78731
The Cataract & Glaucoma Center El Paso Texas 79902
Houston Eye Associates Houston Texas 77024
Kozlovsky Delay & Winter Eye Consultants, LLC Corona Research San Antonio Texas 78213

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02793817, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 15, 2020 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02793817 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →